211 related articles for article (PubMed ID: 30261243)
1. Low-dose aspirin use and risk of contralateral breast cancer: a Danish nationwide cohort study.
Bens A; Friis S; Dehlendorff C; Jensen MB; Ejlertsen B; Kroman N; Cronin-Fenton D; Mellemkjær L
Prev Med; 2018 Nov; 116():186-193. PubMed ID: 30261243
[TBL] [Abstract][Full Text] [Related]
2. Nonaspirin NSAIDs and contralateral breast cancer risk.
Bens A; Cronin-Fenton D; Dehlendorff C; Jensen MB; Ejlertsen B; Kroman N; Friis S; Mellemkjaer L
Int J Cancer; 2019 Mar; 144(6):1243-1250. PubMed ID: 30362513
[TBL] [Abstract][Full Text] [Related]
3. Mortality after contralateral breast cancer in Denmark.
Langballe R; Frederiksen K; Jensen MB; Andersson M; Cronin-Fenton D; Ejlertsen B; Mellemkjær L
Breast Cancer Res Treat; 2018 Sep; 171(2):489-499. PubMed ID: 29948403
[TBL] [Abstract][Full Text] [Related]
4. Low-dose aspirin use and endometrial cancer mortality-a Danish nationwide cohort study.
Sperling CD; Verdoodt F; Aalborg GL; Dehlendorff C; Friis S; Kjaer SK
Int J Epidemiol; 2020 Feb; 49(1):330-337. PubMed ID: 31845990
[TBL] [Abstract][Full Text] [Related]
5. Low-dose aspirin use and the risk of ovarian cancer in Denmark.
Baandrup L; Kjaer SK; Olsen JH; Dehlendorff C; Friis S
Ann Oncol; 2015 Apr; 26(4):787-792. PubMed ID: 25538177
[TBL] [Abstract][Full Text] [Related]
6. Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.
Baandrup L
Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183052
[TBL] [Abstract][Full Text] [Related]
7. Low-dose Aspirin, Nonsteroidal Anti-inflammatory Drugs, Selective COX-2 Inhibitors and Breast Cancer Recurrence.
Cronin-Fenton DP; Heide-Jørgensen U; Ahern TP; Lash TL; Christiansen P; Ejlertsen B; Sørensen HT
Epidemiology; 2016 Jul; 27(4):586-93. PubMed ID: 27007644
[TBL] [Abstract][Full Text] [Related]
8. Associations of low-dose aspirin or other NSAID use with prostate cancer risk in the Danish Diet, Cancer and Health Study.
Skriver C; Dehlendorff C; Borre M; Brasso K; Larsen SB; Tjønneland A; Pottegård A; Hallas J; Sørensen HT; Friis S
Cancer Causes Control; 2020 Feb; 31(2):139-151. PubMed ID: 31823168
[TBL] [Abstract][Full Text] [Related]
9. Use of Low-Dose Aspirin and Mortality After Prostate Cancer Diagnosis: A Nationwide Cohort Study.
Skriver C; Dehlendorff C; Borre M; Brasso K; Larsen SB; Dalton SO; Nørgaard M; Pottegård A; Hallas J; Sørensen HT; Friis S
Ann Intern Med; 2019 Apr; 170(7):443-452. PubMed ID: 30831581
[TBL] [Abstract][Full Text] [Related]
10. The role of H1 antihistamines in contralateral breast cancer: a Danish nationwide cohort study.
Bens A; Dehlendorff C; Friis S; Cronin-Fenton D; Jensen MB; Ejlertsen B; Lash TL; Kroman N; Mellemkjær L
Br J Cancer; 2020 Mar; 122(7):1102-1108. PubMed ID: 32063603
[TBL] [Abstract][Full Text] [Related]
11. Reproductive history and risk of second primary breast cancer: the WECARE study.
Largent JA; Capanu M; Bernstein L; Langholz B; Mellemkaer L; Malone KE; Begg CB; Haile RW; Lynch CF; Anton-Culver H; Wolitzer A; Bernstein JL
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):906-11. PubMed ID: 17507614
[TBL] [Abstract][Full Text] [Related]
12. Statin use and risk of contralateral breast cancer: a nationwide cohort study.
Langballe R; Cronin-Fenton D; Dehlendorff C; Jensen MB; Ejlertsen B; Andersson M; Friis S; Mellemkjær L
Br J Cancer; 2018 Nov; 119(10):1297-1305. PubMed ID: 30353047
[TBL] [Abstract][Full Text] [Related]
13. No association between low-dose aspirin use and breast cancer outcomes overall: a Swedish population-based study.
Frisk G; Ekberg S; Lidbrink E; Eloranta S; Sund M; Fredriksson I; Lambe M; Smedby KE
Breast Cancer Res; 2018 Nov; 20(1):142. PubMed ID: 30458873
[TBL] [Abstract][Full Text] [Related]
14. Non-aspirin NSAIDs and head and neck cancer mortality in a Danish nationwide cohort study.
de la Cour CD; Dehlendorff C; von Buchwald C; Garset-Zamani M; Grønhøj C; Carlander AF; Friis S; Kjaer SK
Cancer Epidemiol; 2022 Apr; 77():102121. PubMed ID: 35183905
[TBL] [Abstract][Full Text] [Related]
15. Nonsteroidal anti-inflammatory drug use and breast cancer risk: a Danish cohort study.
Friis S; Thomassen L; Sørensen HT; Tjønneland A; Overvad K; Cronin-Fenton DP; Vogel U; McLaughlin JK; Blot WJ; Olsen JH
Eur J Cancer Prev; 2008 Apr; 17(2):88-96. PubMed ID: 18287865
[TBL] [Abstract][Full Text] [Related]
16. Use of beta-blockers and risk of contralateral breast cancer.
Gottschau M; Bens A; Friis S; Cronin-Fenton D; Aalborg GL; Jensen MB; Ejlertsen B; Kroman N; Mellemkjaer L
Int J Cancer; 2022 May; 150(10):1619-1626. PubMed ID: 34985760
[TBL] [Abstract][Full Text] [Related]
17. Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study.
Langballe R; Mellemkjær L; Malone KE; Lynch CF; John EM; Knight JA; Bernstein L; Brooks J; Andersson M; Reiner AS; Liang X; Woods M; Concannon PJ; ; Bernstein JL
Breast Cancer Res; 2016 Jul; 18(1):65. PubMed ID: 27400983
[TBL] [Abstract][Full Text] [Related]
18. Low-dose aspirin use and survival in breast cancer patients: A nationwide cohort study.
Mc Menamin ÚC; Cardwell CR; Hughes CM; Murray LJ
Cancer Epidemiol; 2017 Apr; 47():20-27. PubMed ID: 28088656
[TBL] [Abstract][Full Text] [Related]
19. Risk of contralateral breast cancer according to first breast cancer characteristics among women in the USA, 1992-2016.
Ramin C; Withrow DR; Davis Lynn BC; Gierach GL; Berrington de González A
Breast Cancer Res; 2021 Feb; 23(1):24. PubMed ID: 33596988
[TBL] [Abstract][Full Text] [Related]
20. Regular and low-dose aspirin, other non-steroidal anti-inflammatory medications and prospective risk of HER2-defined breast cancer: the California Teachers Study.
Clarke CA; Canchola AJ; Moy LM; Neuhausen SL; Chung NT; Lacey JV; Bernstein L
Breast Cancer Res; 2017 May; 19(1):52. PubMed ID: 28460643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
